ArticleCancer science2025

Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells.

Hiromi Muraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.